William R. Kem

Proof-of-Concept Trial of an α7 Nicotinic Agonist in Schizophrenia

Ann Olincy, Josette G. Harris, Lynn Johnson et al. · Archives of General Psychiatry · 2006 · 526 citations

Medicine, Neuroscience, Pharmacology +17

Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

Robert Freedman, Ann Olincy, Robert W. Buchanan et al. · American Journal of Psychiatry · 2008 · 424 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Selective α 7 -nicotinic agonists normalize inhibition of auditory response in DBA mice

Karen E. Stevens, William R. Kem, Vladimir M. Mahnir et al. · Psychopharmacology · 1998 · 267 citations

Medicine, Neuroscience, Pharmacology +15

ShK-Dap22, a Potent Kv1.3-specific Immunosuppressive Polypeptide

Katalin Kálmán, Michael W. Pennington, Mark D. Lanigan et al. · Journal of Biological Chemistry · 1998 · 255 citations · Full text

Natural Sciences, Biochemistry, Immunology +17

Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21

Gary W. Arendash, Gregory J. Sengstock, Paul R. Sanberg et al. · Brain Research · 1995 · 199 citations

Social Sciences, Neuroscience, Pharmacology +15